Novavax Inc. buy jomobb
Start price
28.05.21
/
80%
€125.18
Target price
28.05.22
€200.00
Performance (%)
-35.69%
End price
29.01.22
€80.50
Summary
This prediction ended on 29.01.22 with a price of €80.50. The BUY prediction by jomobb for Novavax Inc. performed very badly with a performance of -35.69%. jomobb has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novavax Inc. | 23.775% | 23.775% | 111.768% | -90.119% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies
Comments by jomobb for this prediction
In the thread Novavax Inc. diskutieren
Kombi-Impfstoff